Aprogen Healthcare & Games Inc (109960) - Total Assets
Based on the latest financial reports, Aprogen Healthcare & Games Inc (109960) holds total assets worth ₩324.89 Billion KRW (≈ $220.17 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Aprogen Healthcare & Games Inc (109960) net assets for net asset value and shareholders' equity analysis.
Aprogen Healthcare & Games Inc - Total Assets Trend (2013–2024)
This chart illustrates how Aprogen Healthcare & Games Inc's total assets have evolved over time, based on quarterly financial data.
Aprogen Healthcare & Games Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Aprogen Healthcare & Games Inc's total assets of ₩324.89 Billion consist of 15.7% current assets and 84.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 1.4% |
| Accounts Receivable | ₩2.72 Billion | 0.8% |
| Inventory | ₩1.44 Billion | 0.4% |
| Property, Plant & Equipment | ₩4.60 Billion | 1.4% |
| Intangible Assets | ₩2.30 Million | 0.0% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Aprogen Healthcare & Games Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 109960 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aprogen Healthcare & Games Inc's current assets represent 15.7% of total assets in 2024, a decrease from 69.7% in 2013.
- Cash Position: Cash and equivalents constituted 1.4% of total assets in 2024, down from 16.4% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2013.
- Asset Diversification: The largest asset category is property, plant & equipment at 1.4% of total assets.
Aprogen Healthcare & Games Inc Competitors by Total Assets
Key competitors of Aprogen Healthcare & Games Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
KPX Lifescience.Co.Ltd
KQ:114450
|
Korea | ₩50.34 Billion |
|
GeneBioTech Co. Ltd
KQ:086060
|
Korea | ₩75.43 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩233.98 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩87.88 Billion |
Aprogen Healthcare & Games Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.20 | 2.38 | 28.30 |
| Quick Ratio | 4.08 | 2.30 | 27.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩42.28 Billion | ₩45.61 Billion | ₩97.33 Billion |
Aprogen Healthcare & Games Inc - Advanced Valuation Insights
This section examines the relationship between Aprogen Healthcare & Games Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.19 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 5.8% |
| Total Assets | ₩334.89 Billion |
| Market Capitalization | $18.53 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aprogen Healthcare & Games Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Aprogen Healthcare & Games Inc's assets grew by 5.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Aprogen Healthcare & Games Inc (2013–2024)
The table below shows the annual total assets of Aprogen Healthcare & Games Inc from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩334.89 Billion ≈ $226.95 Million |
+5.79% |
| 2023-12-31 | ₩316.56 Billion ≈ $214.53 Million |
+48.34% |
| 2022-12-31 | ₩213.39 Billion ≈ $144.61 Million |
-5.89% |
| 2021-12-31 | ₩226.74 Billion ≈ $153.66 Million |
-4.28% |
| 2020-12-31 | ₩236.89 Billion ≈ $160.54 Million |
+8.49% |
| 2019-12-31 | ₩218.36 Billion ≈ $147.98 Million |
-8.22% |
| 2018-12-31 | ₩237.93 Billion ≈ $161.24 Million |
+67.85% |
| 2017-12-31 | ₩141.75 Billion ≈ $96.06 Million |
+807.95% |
| 2016-12-31 | ₩15.61 Billion ≈ $10.58 Million |
-42.41% |
| 2015-12-31 | ₩27.11 Billion ≈ $18.37 Million |
+123.87% |
| 2013-12-31 | ₩12.11 Billion ≈ $8.21 Million |
-- |
About Aprogen Healthcare & Games Inc
Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for … Read more